SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-017937
Filing Date
2020-08-14
Accepted
2020-08-14 10:02:07
Documents
50
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q relv20200630_10q.htm 10-Q 1224163
2 EXHIBIT 31.1 ex_198177.htm EX-31.1 11519
3 EXHIBIT 31.2 ex_198178.htm EX-31.2 11363
4 EXHIBIT 32 ex_198179.htm EX-32 6094
  Complete submission text file 0001437749-20-017937.txt   4477395

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT relv-20200630.xml EX-101.INS 799294
6 XBRL TAXONOMY EXTENSION SCHEMA relv-20200630.xsd EX-101.SCH 40925
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE relv-20200630_cal.xml EX-101.CAL 44720
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE relv-20200630_def.xml EX-101.DEF 280603
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE relv-20200630_lab.xml EX-101.LAB 267000
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE relv-20200630_pre.xml EX-101.PRE 299052
Mailing Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405
Business Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405 636-537-9715
RELIV INTERNATIONAL INC (Filer) CIK: 0000768710 (see all company filings)

IRS No.: 371172197 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19932 | Film No.: 201102080
SIC: 2834 Pharmaceutical Preparations